AUTL
Autolus Therapeutics plc
1.80$
-3.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +337.2% | +468.5% | -100.0% | – | – | +30,872.4% | +132.9% | +1.3% | +14.4% | +8.1% | +74.3% | – | |
| – | +16.4% | +1.7% | +4.9% | -35.7% | +11,255.0% | -87.0% | +36.2% | +17.2% | -11.7% | -2.9% | -16.7% | – | |
| – | – | – | -122.9% | – | – | – | – | – | – | – | +1,428.5% | – | |
| – | -22.2% | +21.9% | +19.4% | +10.1% | +25.3% | -47.1% | +2.6% | +1.7% | +27.6% | -40.4% | +31.5% | – | |
| – | +48.2% | +15.6% | +20.5% | +24.8% | +146.7% | -56.2% | +2.5% | +19.9% | -1.3% | +11.6% | +3.0% | – | |
| – | -8.9% | +20.3% | +25.3% | +14.8% | +52.5% | -45.5% | +2.5% | +11.2% | +11.1% | -14.2% | +12.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +500.9% | -36.0% | -47.2% | +5.0% | +188.6% | -67.1% | -32.7% | +54.0% | +116.8% | -51.3% | -75.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.1% | – | -56.9% | +6,545.5% | +52.2% | -82.2% | +34.0% | -322.0% | – | -46.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.